Testagen (Langford Research Institute)


Welcome to the PulseAid listing for the Testagen drug offered from Langford Research Institute. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Langford Research Institute
NON-PROPRIETARY NAME: Testosterone
SUBSTANCE NAME: (1,2,6,7-3H)TESTOSTERONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: TRANSDERMAL
DOSAGE FORM: AEROSOL, SPRAY
MARKETING CATEGORY NAME: IND
START MARKETING DATE: 2016-12-30
END MARKETING DATE: 0000-00-00


Testagen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTestagen from Langford Research Institute
LABELER NAME: Langford Research Institute
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/50mg)
START MARKETING DATE: 2016-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70304-001_44e4944f-3e81-5b60-e054-00144ff8d46c
PRODUCT NDC: 70304-001
APPLICATION NUMBER: IND101271

Other (1,2,6,7-3H)TESTOSTERONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Langford Research InstituteTestagen